Next Steps in Research in R/R MCL
R/R MCL: Applying Data Into Clinical Practice
R/R MCL: Treating With CAR-T
Rationale for CAR-T to Treat R/R MCL
Mantle Cell Lymphoma: Overview and Standard of Care
Case Overview: 66-Year-Old Woman With MCL
A 66-Year-Old Woman With Mantle Cell Lymphoma
Javier Munoz, MD, MS, FACP, of the Mayo Clinic, considers the appropriateness for CAR T-cell therapy for a 66-year-old woman with relapsed/refractory mantle cell lymphoma.